Inspira Technologies Oxy B H N Ltd (IINN) Return on Investment ROI from the fourth quarter of 2024 to fourth quarter of 2022 and for the year 2024, average high and low, overall ranking from Dec 31 2024 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Inspira Technologies Oxy B H N Ltd  (NASDAQ: IINN)


Inspira Technologies Oxy B H N Ltd's ROI from its fourth quarter of 2024 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Inspira Technologies Oxy B H N Ltd's ROI in the fourth quarter of 2024?
Inspira Technologies Oxy B H N Ltd achieved a return on average invested assets (ROI) of 361.06 % in its fourth quarter of 2024, this is above IINN's average return on investment of -129.04%.
Inspira Technologies Oxy B H N Ltd invested over the 12 months ending in its fourth quarter of 2024 $3 million

ROI has improved compared to 0% in the third quarter of 2024, due to net income growth.

Within the Healthcare sector 988 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2024 from to 28.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM -51.41 % -55.75 % -57.42 % -60.76 % -56.57 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 2 1 4 4 5
Return On Investment (TTM) 361.06 % 0 % 0 % 0 % 0 %
IINN's Overall Ranking # 28 # # # # 5335
Seq. Investment Change TTM -19.78 % -16.63 % -13.06 % -16.44 % -26.94 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 11 0 0 0 0

IINN Company Profile >> Back to IINN Roi Comparisons >> See Annual IINN Return On Investment



Return On Investment IINN's Ranking
Within: No.
Industry # 213
Sector # 989
Overall # 28

Return On Investment Statistics
High Average Low
235.17 %
-129.04 %
-489.45 %
(Dec 31 2024)   (Dec 31 2025)







Financial Statements
Inspira Technologies Oxy B H N Ltd's IV. Quarter Investments $ 2 Millions IINN's Balance sheet
Inspira Technologies Oxy B H N Ltd's IV. Quarter Income $ 11 Millions Quarterly IINN's Income Statement
IINN's Income by Division See IINN's Income by Division


IINN Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 2 4 7 15 25
Y / Y Investment Growth -46.25 % -38.89 % -51.67 % -41.29 % -
Net Income in Millions -13 11 -11 -15 -17
Y / Y Net Income Growth - - - - -
Annual Return On Investment -569.09 % 255.74 % -159.56 % -102.32 % -68.97 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IINN's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IINN's Competitors
Subscribers only: Roi for Inspira Technologies Oxy B H N Ltd's Suppliers
Subscribers only: Return On Investment for IINN's Customers

Other Ratios
IINN's Roa IINN's Inventory Turnover Ratio IINN's Growth Rates IINN's Dividend Statistics
IINN's Profitability Ratios IINN's Asset Turnover Ratio IINN's Dividend Growth
IINN's Roe IINN's Valuation Ratios IINN's Financial Strength Ratios IINN's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2024, within Healthcare Sector ROI
Inhibrx Biosciences Inc   894.58 %
Traws Pharma inc   659.53 %
Ir med Inc   445.51 %
Polypid Ltd  278.02 %
Inspira Technologies Oxy B H N Ltd  235.17 %
Camp4 Therapeutics Corporation  206.47 %
Alumis inc   156.42 %
Longduoduo Co Ltd  152.69 %
Pavmed Inc   149.32 %
Champions Oncology Inc   127.02 %
Cytomx Therapeutics Inc   114.82 %
Oak Woods Acquisition Corp  84.43 %
Earth Science Tech Inc   81.05 %
Addex Therapeutics Ltd  75.10 %

Date modified: 2026-09-02T17:55:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.